All In MedTech

FDA Clearance Tracker · P000027-S005

ELECSYS FREE PSA IMMUNOASSAY, PSA CALSET & PSA CALCHECK

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 3, 2009 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 3, 2009

Approved

Time to decision

589 days

Received Jul 23, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P000027-S005
Device name
ELECSYS FREE PSA IMMUNOASSAY, PSA CALSET & PSA CALCHECK
Applicant location
Indianapolis, IN
Received
Jul 23, 2007
Decided
Mar 3, 2009
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P000027

Device type

Device class
Class III

Every decision under product code MTG

FDA's approval statement

As written in FDA's record.

APPROVAL FOR EXTENSION OF THE ELECSYS TOTAL PSA SYSTEM ONTO AN UPDATED MODEL OF THE MODULAR ANALYTICS E170 ANALYZER, KNOWN AS THE COBAS E411 ANALYZER.

Source documents

Other decisions for Roche Diagnostics Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.